213 related articles for article (PubMed ID: 34932603)
1. Abdominal pain and cirrhosis at diagnosis of hemochromatosis: Analysis of 219 referred probands with HFE p.C282Y homozygosity and a literature review.
Barton JC; Barton JC; Patel N; McLaren GD
PLoS One; 2021; 16(12):e0261690. PubMed ID: 34932603
[TBL] [Abstract][Full Text] [Related]
2. Non-alcoholic fatty liver disease in hemochromatosis probands with iron overload and HFE p.C282Y/p.C282Y.
Barton JC; Barton JC; Acton RT
BMC Gastroenterol; 2023 Apr; 23(1):137. PubMed ID: 37118679
[TBL] [Abstract][Full Text] [Related]
3. HLA-A*03, the hemochromatosis ancestral haplotype, and phenotypes of referred hemochromatosis probands with HFE p.C282Y homozygosity.
Barton JC; Barton JC; Acton RT
Hereditas; 2022 Jun; 159(1):25. PubMed ID: 35659379
[TBL] [Abstract][Full Text] [Related]
4. Effect of Native American ancestry on iron-related phenotypes of Alabama hemochromatosis probands with HFE C282Y homozygosity.
Barton JC; Barton EH; Acton RT
BMC Med Genet; 2006 Mar; 7():22. PubMed ID: 16533407
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and characteristics of anti-HCV positivity and chronic hepatitis C virus infection in HFE p.C282Y homozygotes.
Barton JC; Barton JC; Adams PC
Ann Hepatol; 2019; 18(2):354-359. PubMed ID: 31056361
[TBL] [Abstract][Full Text] [Related]
6. Cirrhosis in Hemochromatosis: Independent Risk Factors in 368 HFE p.C282Y Homozygotes.
Barton JC; McLaren CE; Chen WP; Ramm GA; Anderson GJ; Powell LW; Subramaniam VN; Adams PC; Phatak PD; Gurrin LC; Phillips JD; Parker CJ; Emond MJ; McLaren GD
Ann Hepatol; 2018 Aug; 17(5):871-879. PubMed ID: 30145563
[TBL] [Abstract][Full Text] [Related]
7. Platelet counts in
Barton JC; Barton JC; Acton RT
Platelets; 2023 Dec; 34(1):2217933. PubMed ID: 37260121
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune Conditions in 235 Hemochromatosis Probands with HFE C282Y Homozygosity and Their First-Degree Relatives.
Barton JC; Barton JC
J Immunol Res; 2015; 2015():453046. PubMed ID: 26504855
[TBL] [Abstract][Full Text] [Related]
9. Diabetes in first-degree family members: a predictor of type 2 diabetes in 159 nonscreening Alabama hemochromatosis probands with HFE C282Y homozygosity.
Barton JC; Barton JC; Acton RT
Diabetes Care; 2014; 37(1):259-66. PubMed ID: 23990522
[TBL] [Abstract][Full Text] [Related]
10. HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload.
Barton JC; Wiener HW; Acton RT; Go RC
Blood Cells Mol Dis; 2005; 34(1):38-47. PubMed ID: 15607698
[TBL] [Abstract][Full Text] [Related]
11. Increased risk of death from iron overload among 422 treated probands with HFE hemochromatosis and serum levels of ferritin greater than 1000 μg/L at diagnosis.
Barton JC; Barton JC; Acton RT; So J; Chan S; Adams PC
Clin Gastroenterol Hepatol; 2012 Apr; 10(4):412-6. PubMed ID: 22265917
[TBL] [Abstract][Full Text] [Related]
12. Association of Hemochromatosis HFE p.C282Y Homozygosity With Hepatic Malignancy.
Atkins JL; Pilling LC; Masoli JAH; Kuo CL; Shearman JD; Adams PC; Melzer D
JAMA; 2020 Nov; 324(20):2048-2057. PubMed ID: 33231665
[TBL] [Abstract][Full Text] [Related]
13. Common variable immunodeficiency and IgG subclass deficiency in central Alabama hemochromatosis probands homozygous for HFE C282Y.
Barton JC; Bertoli LF; Acton RT
Blood Cells Mol Dis; 2003; 31(1):102-11. PubMed ID: 12850493
[TBL] [Abstract][Full Text] [Related]
14. Chromosome 6p SNP microhaplotypes and IgG3 levels in hemochromatosis probands with HFE p.C282Y homozygosity.
Barton JC; Barton JC; Cruz E; Teles MJ; Guimarães JT; Porto G
Blood Cells Mol Dis; 2020 Nov; 85():102461. PubMed ID: 32623342
[TBL] [Abstract][Full Text] [Related]
15. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD
Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507
[TBL] [Abstract][Full Text] [Related]
16. Differences in hepatic phenotype between hemochromatosis patients with HFE C282Y homozygosity and other HFE genotypes.
Cheng R; Barton JC; Morrison ED; Phatak PD; Krawitt EL; Gordon SC; Kowdley KV
J Clin Gastroenterol; 2009 Jul; 43(6):569-73. PubMed ID: 19359997
[TBL] [Abstract][Full Text] [Related]
17. A genotypic study of 217 unrelated probands diagnosed as "genetic hemochromatosis" on "classical" phenotypic criteria.
Brissot P; Moirand R; Jouanolle AM; Guyader D; Le Gall JY; Deugnier Y; David V
J Hepatol; 1999 Apr; 30(4):588-93. PubMed ID: 10207799
[TBL] [Abstract][Full Text] [Related]
18. GNPAT variant (D519G) is not associated with an elevated serum ferritin or iron removed by phlebotomy in patients referred for C282Y-linked hemochromatosis.
Levstik A; Stuart A; Adams PC
Ann Hepatol; 2016 Nov-Dec 2016; 15(6):907-910. PubMed ID: 27740525
[TBL] [Abstract][Full Text] [Related]
19. Longer survival associated with HLA-A*03, B*14 among 212 hemochromatosis probands with HFE C282Y homozygosity and HLA-A and -B typing and haplotyping.
Barton JC; Barton JC; Acton RT
Eur J Haematol; 2010 Nov; 85(5):439-47. PubMed ID: 20722701
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
